$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model

Journal of controlled release : official journal of the Controlled Release Society, v.150 no.1, 2011년, pp.56 - 62  

Oh, Y.J. (133-791, Republic of Korea) ,  Lee, J. (Department of Internal Medicine, Hanyang University College of Medicine, Seoul 133-791, Republic of Korea) ,  Seo, J.Y. ,  Rhim, T. ,  Kim, S.H. ,  Yoon, H.J. ,  Lee, K.Y.

Abstract AI-Helper 아이콘AI-Helper

Inhaling corticosteroids, such as budesonide (BD), is the most common treatment for asthma. However, frequent steroid administration is associated with many side effects. We hypothesized that porous microparticles containing BD could provide an effective treatment method for asthma, as t...

주제어

참고문헌 (36)

  1. Immunol. Cell Biol. Kumar 79 141 2001 10.1046/j.1440-1711.2001.00981.x Murine model of chronic human asthma 

  2. J. Appl. Physiol. Edwards 84 379 1998 10.1152/jappl.1998.85.2.379 Recent advances in pulmonary drug delivery using large, porous inhaled particles 

  3. Eur. J. Pharm. Sci. Adi 35 12 2008 10.1016/j.ejps.2008.05.009 Micro-particle corrugation, adhesion and inhalation aerosol efficiency 

  4. Br. Med. J. Brown 1 585 1972 10.1136/bmj.1.5800.585 Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma 

  5. J. Clin. Endocrinol. Metab. Samaras 90 4394 2005 10.1210/jc.2005-0036 Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases 

  6. Int. J. Pharm. Varshosaz 365 69 2009 10.1016/j.ijpharm.2008.08.034 Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis 

  7. J. Control. Release Nakamura 61 329 1999 10.1016/S0168-3659(99)00150-9 Uptake and release of budesonide from mucoadhesive, pH-sensitive copolymers and their application to nasal delivery 

  8. J. Pharm. Sci. El-gendy 98 2731 2009 10.1002/jps.21630 Budesondie nanoparticle agglomerates as dry powder aerosols with rapid dissolution 

  9. Int. J. Pharm. Krishnamachari 338 238 2007 10.1016/j.ijpharm.2007.02.015 Development of pH-and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon 

  10. Respir. Med. Dahl 100 1307 2006 10.1016/j.rmed.2005.11.020 Systemic side effects of inhaled corticosteroids in patients with asthma 

  11. Trends Biotechnol. Sung 25 563 2007 10.1016/j.tibtech.2007.09.005 Nanoparticles for drug delivery to the lungs 

  12. Proc. Natl Acad. Sci. USA Tsapis 99 12001 2002 10.1073/pnas.182233999 Trojan particles: large porous carriers of nanoparticles for drug delivery 

  13. Pharm. Res. Fiegel 20 788 2003 10.1023/A:1023441804464 Large porous particle impingement on lung epithelial cell monolayers-toward improved particle characterization in the lung 

  14. J. Control. Release Chono 137 104 2009 10.1016/j.jconrel.2009.03.019 Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery 

  15. J. Control. Release Cook 104 79 2005 10.1016/j.jconrel.2005.01.003 Novel sustained release microspheres for pulmonary drug delivery 

  16. Science Edwards 276 1868 1997 10.1126/science.276.5320.1868 Large porous particles for pulmonary drug delivery 

  17. J. Pharm. Sci. Xu 98 2377 2009 10.1002/jps.21612 Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microsphereas 

  18. Biomaterials Kumar 25 1771 2004 10.1016/j.biomaterials.2003.08.069 Preparation and characterization of cationic PLGA nanospheres as DNA carriers 

  19. Eur. J. Pharm. Sci. Lee 29 435 2006 10.1016/j.ejps.2006.08.005 In vitro study of lysozyme in poly(lactide-co-glycolide) microspheres with sucrose acetate isobutyrate 

  20. Colloids Surf. B Xie 67 199 2008 10.1016/j.colsurfb.2008.08.018 Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles 

  21. J. Control. Release Rawat 128 224 2008 10.1016/j.jconrel.2008.03.013 Inhalable large porous microparticles of low molecular weight heparin: in vitro and in vivo evaluation 

  22. J. Control. Release Ungaro 135 25 2009 10.1016/j.jconrel.2008.12.011 Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vitro deposition and hypoglycaemic activity after delivery to rat lungs 

  23. Biomaterials Yang 30 1947 2009 10.1016/j.biomaterials.2008.12.044 Development of highly porous large PLGA microparticles for pulmonary drug delivery 

  24. Biomaterials Jain 21 2475 2000 10.1016/S0142-9612(00)00115-0 The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices 

  25. Eur. J. Pharm. Sci. Ungaro 28 423 2006 10.1016/j.ejps.2006.05.005 Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs 

  26. J. Pharm. Pharmacol. Bandi 57 851 2005 10.1211/0022357056334 Intratracheal budesonide-poly(lactide-co-glycolide) microparticles reduce oxidative stress, VEGF expression, and vascular leakage in a benzo(a)pyrene-fed mouse model 

  27. J. Appl. Physiol. Wager 96 2019 2004 10.1152/japplphysiol.00924.2003 The allergic mouse model of asthma: normal smooth muscle in an abnormal lung? 

  28. J. Control. Release Arnold 121 100 2007 10.1016/j.jconrel.2007.05.039 Nanocipro encapsulation in monodisperse large porous PLGA microparticles 

  29. Polymer Mikos 35 1068 1994 10.1016/0032-3861(94)90953-9 Preparation and characterization of poly(l-lactic acid) foams 

  30. J. Control. Release Kim 112 167 2006 10.1016/j.jconrel.2006.02.004 Biodegradable polymic microspheres with “open/closed” pores for sustained release of human growth hormone 

  31. Int. J. Pharm. Kwon 333 5 2007 10.1016/j.ijpharm.2007.01.016 Long acting porous microparticle for pulmonary protein delivery 

  32. Biomaterials Kim 27 152 2006 10.1016/j.biomaterials.2005.05.081 Gas foamed open porous biodegradable polymeric microspheres 

  33. J. Toxicol. Environ. Health Schlesinger 15 197 1985 10.1080/15287398509530647 Comparative deposition of inhaled aerosols in experimental animals and humans: a review 

  34. Pharm. Res. Koushik 21 524 2004 10.1023/B:PHAM.0000019308.25479.a4 Preparation of large porous deslorelin-PLGA microparticles with reduced residual solvent and cellular uptake using a supercritical carbon dioxide process 

  35. Pharm. Res. Koushik 21 1119 2004 10.1023/B:PHAM.0000032997.96823.88 Pulmonary delivery of deslorelin: large-porous PLGA particles and HPβCD complexes 

  36. Am. J. Respir. Crit. Care Med. Hamelmann 156 766 1997 10.1164/ajrccm.156.3.9606031 Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography 

LOADING...

관련 콘텐츠

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로